(Q43153839)

14 November 2017

To protect peptide pharmaceuticals against peptidases (English)

1 reference

14 November 2017

R Rink

1

1 reference

14 November 2017

A Arkema-Meter

2

1 reference

14 November 2017

I Baudoin

3

1 reference

14 November 2017

E Post

4

1 reference

14 November 2017

A Kuipers

5

1 reference

14 November 2017

S A Nelemans

6

1 reference

14 November 2017

M Haas Jimoh Akanbi

7

1 reference

14 November 2017

G N Moll

8

1 reference

14 November 2017

20 February 2010

1 reference

Journal of Pharmacological and Toxicological Methods

14 November 2017

1 reference

14 November 2017

61

1 reference

14 November 2017

2

1 reference

14 November 2017

210-218

1 reference

Structure-function studies of linear and cyclized peptide antagonists of the GnRH receptor

14 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.02.010

All-D-magainin: chirality, antimicrobial activity and proteolytic resistance.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.02.010

Conformational analysis of a highly potent dicyclic gonadotropin-releasing hormone antagonist by nuclear magnetic resonance and molecular dynamics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.02.010

A rapid method for the preparation of microvilli from rabbit kidney

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.02.010

Amidation of growth hormone releasing factor (1-29) by serine carboxypeptidase catalysed transpeptidation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.02.010

Molecular cloning and nucleotide sequence of the gene encoding the major peptidoglycan hydrolase of Lactococcus lactis, a muramidase needed for cell separation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.02.010

Polyfluoroalkylamine derivatives of luteinizing hormone-releasing hormone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.02.010

Conformationally restrained cyclic peptides as antagonists of luteinizing hormone-releasing hormone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.02.010

Identification in pituitary tissue of a peptide alpha-amidation activity that acts on glycine-extended peptides and requires molecular oxygen, copper, and ascorbic acid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.02.010

Understanding base-assisted desulfurization using a variety of disulfide-bridged peptides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.02.010

Immunocytochemical finding of the amidating enzymes in mouse pancreatic A-, B-, and D-cells: a comparison with human and rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.02.010

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.02.010

Effect of D-amino acid substitution on the stability, the secondary structure, and the activity of membrane-active peptide.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.02.010

Post-translational modification of therapeutic peptides by NisB, the dehydratase of the lantibiotic nisin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.02.010

Angiotensin-(1-7) with thioether bridge: an angiotensin-converting enzyme-resistant, potent angiotensin-(1-7) analog

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.02.010

Autoregulation of nisin biosynthesis in Lactococcus lactis by signal transduction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.02.010

Controlled overproduction of proteins by lactic acid bacteria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.02.010

NisT, the transporter of the lantibiotic nisin, can transport fully modified, dehydrated, and unmodified prenisin and fusions of the leader peptide with non-lantibiotic peptides.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.02.010

Cyclization strategies in peptide derived drug design

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.02.010

Structure and mechanism of the lantibiotic cyclase involved in nisin biosynthesis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.02.010

Synthesis of gonadotropin-releasing hormone III analogs. Structure-antitumor activity relationships

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.02.010

New derivatives of GnRH as potential anticancer therapeutic agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.02.010

Lanthionine-somatostatin analogs: synthesis, characterization, biological activity, and enzymatic stability studies.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.02.010

Synthesis and biological activities of cyclic lanthionine enkephalin analogues: delta-opioid receptor selective ligands

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.02.010

Lantibiotic structures as guidelines for the design of peptides that can be modified by lantibiotic enzymes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.02.010

Production of dehydroamino acid-containing peptides by Lactococcus lactis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.02.010

Dissection and modulation of the four distinct activities of nisin by mutagenesis of rings A and B and by C-terminal truncation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.02.010

NisC, the cyclase of the lantibiotic nisin, can catalyze cyclization of designed nonlantibiotic peptides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.02.010

Design of potent dicyclic (1-5/4-10) gonadotropin releasing hormone (GnRH) antagonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.02.010

Design of monocyclic (1-3) and dicyclic (1-3/4-10) gonadotropin releasing hormone (GnRH) antagonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.02.010

Design of potent dicyclic (4-10/5-8) gonadotropin releasing hormone (GnRH) antagonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.02.010

Molecular mechanisms of ligand interaction with the gonadotropin-releasing hormone receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.02.010

Construction of a vector plasmid family and its use for molecular cloning in Streptococcus lactis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.02.010

The effect of cyclization on the enzymatic degradation of herpes simplex virus glycoprotein D derived epitope peptide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.02.010

Minimal Requirements for Exponential Growth of Lactococcus lactis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.02.010

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VASCN.2010.02.010

1 reference

14 November 2017

1 reference